KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Fulgent Genetics (FLGT) Interest & Investment Income (2016 - 2025)

Fulgent Genetics' Interest & Investment Income history spans 11 years, with the latest figure at $6.9 million for Q4 2025.

  • For Q4 2025, Interest & Investment Income fell 14.61% year-over-year to $6.9 million; the TTM value through Dec 2025 reached $30.9 million, down 1.23%, while the annual FY2025 figure was $30.9 million, 1.23% down from the prior year.
  • Interest & Investment Income for Q4 2025 was $6.9 million at Fulgent Genetics, down from $7.9 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $8.1 million in Q4 2024 and bottomed at -$35000.0 in Q4 2021.
  • The 5-year median for Interest & Investment Income is $5.5 million (2023), against an average of $4.5 million.
  • The largest annual shift saw Interest & Investment Income plummeted 105.94% in 2021 before it skyrocketed 9288.57% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at -$35000.0 in 2021, then surged by 9288.57% to $3.2 million in 2022, then surged by 80.66% to $5.8 million in 2023, then surged by 39.81% to $8.1 million in 2024, then decreased by 14.61% to $6.9 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Interest & Investment Income are $6.9 million (Q4 2025), $7.9 million (Q3 2025), and $8.1 million (Q2 2025).